Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.470
-0.030 (-2.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $43.50 million as of February 21, 2025. Its market cap has increased by 1.39% in one year.
Market Cap
43.50M
Enterprise Value
38.94M
1-Year Change
1.39%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $43.50M, a decrease of -54.12%. That is a compound annual growth rate of -12.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 43.50M | -16.02% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |